Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing

Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing

Submitted by admin on October 20, 2022 - 11:24pm
Source: 
BioSpace
News Tags: 
Erasca
Pfizer
ERAS-007
Ibrance
colorectal cancer
Headline: 
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
snippet: 

California-based Erasca announced Thursday it is expanding its existing partnership with Pfizer to assess ERAS-007 in combination with Pfizer's Ibrance (palbociclib).

Do Not Allow Advertisers to Use My Personal information